S&P 500   4,213.99 (+0.20%)
DOW   32,977.19 (-0.35%)
QQQ   351.06 (+0.76%)
AAPL   177.31 (+1.07%)
MSFT   332.96 (+0.02%)
META   265.17 (+1.19%)
GOOGL   123.72 (-0.71%)
AMZN   121.36 (+1.04%)
TSLA   200.39 (+3.74%)
NVDA   408.96 (+5.01%)
NIO   7.65 (-0.65%)
BABA   79.23 (-2.15%)
AMD   125.61 (-1.12%)
T   15.54 (+0.26%)
F   12.59 (+4.14%)
MU   72.41 (-2.06%)
CGC   0.86 (-1.57%)
GE   101.22 (-1.48%)
DIS   87.84 (-0.51%)
AMC   4.61 (-0.65%)
PFE   37.04 (-1.49%)
PYPL   60.00 (-0.37%)
NFLX   394.36 (+4.09%)
S&P 500   4,213.99 (+0.20%)
DOW   32,977.19 (-0.35%)
QQQ   351.06 (+0.76%)
AAPL   177.31 (+1.07%)
MSFT   332.96 (+0.02%)
META   265.17 (+1.19%)
GOOGL   123.72 (-0.71%)
AMZN   121.36 (+1.04%)
TSLA   200.39 (+3.74%)
NVDA   408.96 (+5.01%)
NIO   7.65 (-0.65%)
BABA   79.23 (-2.15%)
AMD   125.61 (-1.12%)
T   15.54 (+0.26%)
F   12.59 (+4.14%)
MU   72.41 (-2.06%)
CGC   0.86 (-1.57%)
GE   101.22 (-1.48%)
DIS   87.84 (-0.51%)
AMC   4.61 (-0.65%)
PFE   37.04 (-1.49%)
PYPL   60.00 (-0.37%)
NFLX   394.36 (+4.09%)
S&P 500   4,213.99 (+0.20%)
DOW   32,977.19 (-0.35%)
QQQ   351.06 (+0.76%)
AAPL   177.31 (+1.07%)
MSFT   332.96 (+0.02%)
META   265.17 (+1.19%)
GOOGL   123.72 (-0.71%)
AMZN   121.36 (+1.04%)
TSLA   200.39 (+3.74%)
NVDA   408.96 (+5.01%)
NIO   7.65 (-0.65%)
BABA   79.23 (-2.15%)
AMD   125.61 (-1.12%)
T   15.54 (+0.26%)
F   12.59 (+4.14%)
MU   72.41 (-2.06%)
CGC   0.86 (-1.57%)
GE   101.22 (-1.48%)
DIS   87.84 (-0.51%)
AMC   4.61 (-0.65%)
PFE   37.04 (-1.49%)
PYPL   60.00 (-0.37%)
NFLX   394.36 (+4.09%)
S&P 500   4,213.99 (+0.20%)
DOW   32,977.19 (-0.35%)
QQQ   351.06 (+0.76%)
AAPL   177.31 (+1.07%)
MSFT   332.96 (+0.02%)
META   265.17 (+1.19%)
GOOGL   123.72 (-0.71%)
AMZN   121.36 (+1.04%)
TSLA   200.39 (+3.74%)
NVDA   408.96 (+5.01%)
NIO   7.65 (-0.65%)
BABA   79.23 (-2.15%)
AMD   125.61 (-1.12%)
T   15.54 (+0.26%)
F   12.59 (+4.14%)
MU   72.41 (-2.06%)
CGC   0.86 (-1.57%)
GE   101.22 (-1.48%)
DIS   87.84 (-0.51%)
AMC   4.61 (-0.65%)
PFE   37.04 (-1.49%)
PYPL   60.00 (-0.37%)
NFLX   394.36 (+4.09%)
CVE:VRS

Verisante Technology (VRS) Stock Forecast, Price & News

C$0.02
+0.02 (+∞)
(As of 04/23/2018)
Compare
Today's Range
C$0.02
C$0.02
50-Day Range
C$0.02
C$0.02
52-Week Range
C$0.01
C$0.06
Volume
197,000 shs
Average Volume
256,747 shs
Market Capitalization
C$1.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Verisante Technology

Verisante Technology Inc., a medical device company, engages in commercializing skin cancer detection systems. The company's products comprise Verisante Aura, which helps in the detection of various forms of skin cancer, including basal cell and squamous cell carcinoma, and melanoma; and Verisante Core for the detection of lung, cervical, gastrointestinal, and colo-rectal cancers. It also owns all the rights to the ClearVu and ClearVu Elite endoscopy systems for the detection of lung cancer. Verisante Technology has a licensing agreement with the BC Cancer Agency for the manufacture, distribution, and sale of products based on patented skin cancer detection technology. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was founded in 2006 and is based in Richmond, Canada.

Receive VRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verisante Technology and its competitors with MarketBeat's FREE daily newsletter.

VRS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive VRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verisante Technology and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Medical Appliances & Equipment
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Web
N/A
Fax
N/A
Employees
1,700
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$1.97 million
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. Thomas A. Braun BA (Age 50)
    J.D., LLM, Chief Exec. Officer, Pres and Director
  • Ms. Anna Trinh B.Comm LLB (Age 44)
    Chief Financial Officer, Corp. Counsel and Sec.
  • Mr. Rizah Bahic
    Exec. Officer













VRS Stock - Frequently Asked Questions

How have VRS shares performed in 2023?

Verisante Technology's stock was trading at C$0.02 at the beginning of the year. Since then, VRS shares have increased by 0.0% and is now trading at C$0.02.
View the best growth stocks for 2023 here
.

What is Verisante Technology's stock symbol?

Verisante Technology trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VRS."

How do I buy shares of Verisante Technology?

Shares of VRS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Verisante Technology's stock price today?

One share of VRS stock can currently be purchased for approximately C$0.02.

How much money does Verisante Technology make?

Verisante Technology (CVE:VRS) has a market capitalization of C$1.97 million.

How many employees does Verisante Technology have?

The company employs 1,700 workers across the globe.

How can I contact Verisante Technology?

Verisante Technology's mailing address is 2309 41st Ave W Suite 306, VANCOUVER, BC V6M 2A3, Canada. The company can be reached via phone at +1-604-6050507.

This page (CVE:VRS) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -